Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hodgkin Disease × Contraceptives, Oral × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 7 Solid Tumors 1 Neoplasms 1 Menstruation Disturbances 1 Insulin Resistance 1 Infertility, Female 1 Hodgkin Disease 1 Cardiovascular Diseases 1

Interventions

Cyclophosphamide 115 Peripheral Blood Stem Cell Transplantation 69 fludarabine phosphate 68 Etoposide 68 Filgrastim 58 Mycophenolic Acid 50 Whole-Body Irradiation 48 Tacrolimus 46 Radiotherapy 46 Doxorubicin 46 Melphalan 45 Busulfan 43 Cyclosporine 40 Brentuximab Vedotin 38 Rituximab 36 fludarabine 34 Vinblastine 34 Granulocyte Colony-Stimulating Factor 33 Prednisone 31 Vincristine 28 Bleomycin 28 Antilymphocyte Serum 28 Gemcitabine 27 Methotrexate 26 Dacarbazine 25 Cytarabine 24 Carmustine 20 Ifosfamide 18 Sirolimus 17 Dexamethasone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01014507 2012-06-25

PROFE

University of Cologne

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡